⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

Ifm Therapeutics (United States)

h-index: 6
Total citations: 3,186
Total papers: 13

Homepage: https://www.ifmthera.com/

Recent papers from Ifm Therapeutics (United States)

Abstract LB367: Novel non saccharide glycosaminoglycan mimetic inhibit colorectal cancer stem cells by selectively targeting key tyrosine kinase receptorsCancer Research · 2026
An oral allopregnanolone prodrug bypasses liver metabolism via lymphatic transport enabling bioavailability in animals and humansScience Translational Medicine · 2026
Perspectives of people living with idiopathic pulmonary fibrosis: a qualitative and quantitative studyBMC Pulmonary Medicine · 2025
Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome InhibitorJournal of Medicinal Chemistry · 2025
First‐in‐human safety, tolerability, and pharmacokinetic results of DFV890, an oral low‐molecular‐weight NLRP3 inhibitorClinical and Translational Science · 2024
In situ evaluation of the impact of metformin or verapamil coadministration with vildagliptin on its regional absorption from the rabbit’s intestineBiopharmaceutics & Drug Disposition · 2024
Lipid Nanoparticles for Nucleic Acid Delivery to Endothelial CellsPharmaceutical Research · 2023
Inflammasome sensor NLRP1 disease variant M1184V promotes autoproteolysis and DPP9 complex formation by stabilizing the FIIND domainJournal of Biological Chemistry · 2022
The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic SteatohepatitisFrontiers in Molecular Biosciences · 2021